Neuphoria Therapeutics (NEUP) EBT (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported EBT of -$539856.0 for Q1 2026, down 104.83% year-over-year from $11.2 million in Q1 2025, and down 129.51% on a QoQ basis from $1.8 million in Q4 2025.
Neuphoria Therapeutics (NEUP) has 4 years of EBT data on file, last reported at -$539856.0 in Q1 2026.
- Quarterly EBT fell 104.83% year-over-year to -$539856.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.1 million (down 224.41% YoY) and the FY2025 annual result came in at -$7.1 million, down 290.85% from the prior year.
- EBT fell to -$539856.0 in Q1 2026 per NEUP's latest filing, from $1.8 million in the prior quarter.
- Across five years, EBT topped out at $11.2 million in Q1 2025 and bottomed at -$15.4 million in Q2 2025.
- The 4-year median for EBT is -$1.9 million (2024), against an average of -$1.6 million.
- Peak annual rise in EBT reached 504.85% in 2025, while the deepest fall reached 961.0% in 2025.
- Tracing NEUP's EBT over 4 years: stood at -$4.6 million in 2023, then soared by 57.91% to -$1.9 million in 2024, then surged by 194.7% to $1.8 million in 2025, then sank by 129.51% to -$539856.0 in 2026.
- Per Business Quant, the three latest NEUP EBT figures stand at -$539856.0 (Q1 2026), $1.8 million (Q4 2025), and -$9.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Neuphoria Therapeutics | 28.35 Mn | 8.95 Mn | - | -539,856.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -539,856.00 |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | -9.94 Mn |
| Jun 30, 2025 | -9.15 Mn |
| Mar 31, 2025 | 11.18 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -936,974.00 |
| Jun 30, 2024 | -901,646.00 |
| Mar 31, 2024 | -2.76 Mn |
| Dec 31, 2023 | -4.59 Mn |
| Sep 30, 2023 | -5.51 Mn |